In vivo leptin signaling inhibition reduced Notch and target expression (NICD1, NICD4, Notch3, JAG1 and survivin), suggesting that leptin-Notch crosstalk could be involved in the reported higher incidence, aggressiveness and poor prognosis of breast cancer in obese patients [72]. This evidence concerns the gene LEP and breast cancer.